To support the global biologics manufacturing needs for WRAIR, the U.S. Army, the DoD, and governmental and industrial partners in order to provide medical countermeasures to our Warfighters.

The PBF strives to be the critical transition point for Vaccines and Biologics from R&D to clinical trials as the DoD’s primary in-house Phase 1 biologics manufacturer.